PEC vs Lumosa Therapeutics: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and Lumosa Therapeutics (6535) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ Lumosa Therapeutics

0%+9778%-99%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYLumosa TherapeuticsYoY
Oct 2026NT$2.84 billion+102.0%NT$78,000-54.9%
Sep 2026NT$2.64 billion+100.0%NT$211,000-95.1%
Aug 2026NT$2.62 billion+105.4%NT$9.1 million+5,135.8%
Jul 2026NT$2.51 billion+92.6%NT$78,000-98.9%
Jun 2026NT$2.33 billion+94.9%NT$5 million+233.5%
May 2026NT$2.46 billion+108.5%NT$78,000-64.5%
Apr 2026NT$2.06 billion+68.3%NT$78,000-83.4%
Mar 2026NT$1.94 billion+64.4%NT$503,000-94.3%
Feb 2026NT$1.6 billion+56.7%NT$30,000-25.0%
Jan 2026NT$1.58 billion+49.8%NT$4 million+9,777.5%
Dec 2025NT$1.92 billion+69.9%NT$14 million-19.3%
Nov 2025NT$1.55 billion+53.0%NT$173,000-95.8%
Oct 2025NT$1.4 billion+53.6%NT$173,000+332.5%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16